Active substance
Results for the substance dolutegravir+lamivudine
1 result
About this active substance
The combination of dolutegravir and lamivudine is used for the treatment of HIV infection in adults who are treatment-naive or have a controlled viral load. It works by inhibiting the integration of viral DNA into the host genome and reverse transcriptase.
The medication is taken orally, usually once daily, with the dose adjusted based on the patient's weight and renal function. Common side effects include nausea, insomnia, headaches, and fatigue.
This combination is contraindicated in patients with hypersensitivity to any of the components or severe hepatic impairment. Its use also requires regular monitoring of liver and renal function.
This medication is a modern option for managing HIV infection, offering a simplified and effective regimen for patients.
The medication is taken orally, usually once daily, with the dose adjusted based on the patient's weight and renal function. Common side effects include nausea, insomnia, headaches, and fatigue.
This combination is contraindicated in patients with hypersensitivity to any of the components or severe hepatic impairment. Its use also requires regular monitoring of liver and renal function.
This medication is a modern option for managing HIV infection, offering a simplified and effective regimen for patients.